[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367730-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367730-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","worldwide-research-trends-on-the-immunotherapy-based-treatment-of-ovarian-cancers-a-bibliometric-and-visual-analysis","Worldwide Research Trends on the Immunotherapy-Based Treatment of Ovarian Cancers: A Bibliometric and Visual Analysis","","Worldwide Research Trends on the Immunotherapy-Based Treatment of Ovarian Cancers - A bibliometric and visual analysis examines how immunotherapy research in ovarian cancer has evolved across the past decade. Publications from 2014 to 2024 were retrieved from Web of Science and analyzed using VOSviewer, CiteSpace, and the R-based Bibliometrix toolkit to map output growth, collaboration patterns, and influential work. Results identify major contributors, leading journals, and highly cited studies, while thematic clustering links progress from foundational trials toward precision and biomarker-driven approaches addressing resistance and heterogeneity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/worldwide-research-trends-on-the-immunotherapy-based-treatment-of-ovarian-cancers-a-bibliometric-and-visual-analysis/367730/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/worldwide-research-trends-on-the-immunotherapy-based-treatment-of-ovarian-cancers-a-bibliometric-and-visual-analysis/367730.png","ImageObject",300,407,{"name":42,"@type":43},"eBook King","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of the bibliometric study on immunotherapy for ovarian cancer?","Question",{"text":63,"@type":64},"To analyze research trends in immunotherapy-based treatment for ovarian cancer over the last decade, identifying leading patterns, influential contributors, and development hotspots.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which databases and tools were used to conduct the analysis?",{"text":68,"@type":64},"A systematic literature search was performed in the Web of Science Core Collection, and visualization/analysis was carried out using VOSviewer, CiteSpace, and the R-based Bibliometrix package.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the results indicate about publication trends and key contributors?",{"text":72,"@type":64},"Publication output rose and later stabilized, peaking in 2022. The United States and China were major contributors, with leading institutions such as Harvard University, University of California, and Fudan University.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367730,1790468475,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Journal of Multidisciplinary Healthcare  \n Open Access Full Text Article  \nORIGINAL RESEARCH  \nWorldwide Research Trends on the Immunotherapy-Based Treatment of Ovarian Cancers: A Bibliometric and Visual Analysis  \nLu Yan, Yibin Liu , Zhiqiang Zhang, Feida Du  \nDepartment of Gynecology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China  \nCorrespondence: Yibin Liu, Department of Gynecology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China,  \nEmail [lybykd24@outlook.com](lybykd24@outlook.com)  \n\n| Purpose: Immunotherapy-based treatment has shown significant clinical potential in various cancers. This study provides a comprehensive bibliometric analysis of the immunotherapy landscape in ovarian cancer over the last decade, identifying leading trends, influential contributors, and key areas of development.\u003Cbr>Methods: A systematic literature search was conducted in the Web of Science Core Collection for publications on immunotherapy drugs used in ovarian cancer between 2014 and 2024. Analytical tools such as VOSviewer, CiteSpace, and the R-based Bibliometrix package were employed to visualize trends, collaborations, and major contributions.\u003Cbr>Results: Our dataset of 2123 publications from 2014 to 2024 highlights a rise and stabilization in publication output, peaking in 2022. Leading journals included Cancers and Frontiers in Oncology. Although a recent decline was observed, it may reflect a shift toward refining existing therapies rather than initiating new studies. The United States and China were major contributors, with institutions such as Harvard University, University of California, and Fudan University leading in output. European institutions like Charité Berlin and KU Leuven also played prominent roles, with key researchers including Sehouli J, Vergote I, and Scambia G. Highly cited studies included The Cancer Genome Atlas, which identified critical genetic mutations in high-grade serous ovarian cancer, and landmark trials exploring the addition of bevacizumab to standard therapies. These works emphasize ongoing challenges such as genetic heterogeneity and resistance, driving research toward biomarker-based and personalized therapeutic strategies. Thematic clustering revealed a progression from foundational treatment trials to precision medicine, with focus areas including platinum resistance and neoadjuvant therapies.\u003Cbr>Conclusion: This bibliometric analysis maps the growing research interest in immunotherapy-based approaches for ovarian cancer, highlighting the field’s collaborative and multidisciplinary nature. The findings provide a foundation for identifying influential themesand guiding future investigations into resistance mechanisms and personalized treatment strategies.\u003Cbr>Keywords: ovarian cancer, immunotherapy, bibliometric analysis, publication trends, network analysis |\n| --- |\n| Introduction\u003Cbr>Ovarian cancer (OC) represents one of the most aggressive malignancies within the gynecological spectrum, with a global incidence rate of approximately 6.6 per 100,000 women.1 It ranks as the eighth leading cause of cancerrelated deaths among women, with a five-year survival rate that varies significantly based on the stage at diagnosis.2 Most ovarian cancer cases are diagnosed at an advanced stage (Stage III or IV), primarily due to the lack of effective early detection methods.3 Symptoms are often nonspecific, leading to delays in diagnosis and treatment initiation.4,5\u003Cbr>The conventional treatment paradigm for ovarian cancer has historically revolved around cytoreductive surgery followed by adjuvant chemotherapy, typically involving platinum-based agents6 and taxanes.7 While these approaches have led to initial responses in many patients, the challenge of chemoresistance remains a critical hurdle, as many patients experience recurrence and develop resistance to subsequent lines of therapy.8 This clinical reality has driven the ","cbCaiqhmFtglEvlN","https://ap.wps.com/l/cbCaiqhmFtglEvlN","pdf",14957880,21,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is the purpose of the bibliometric study on immunotherapy for ovarian cancer?\",\"answer\":\"To analyze research trends in immunotherapy-based treatment for ovarian cancer over the last decade, identifying leading patterns, influential contributors, and development hotspots.\"},{\"question\":\"Which databases and tools were used to conduct the analysis?\",\"answer\":\"A systematic literature search was performed in the Web of Science Core Collection, and visualization/analysis was carried out using VOSviewer, CiteSpace, and the R-based Bibliometrix package.\"},{\"question\":\"What do the results indicate about publication trends and key contributors?\",\"answer\":\"Publication output rose and later stabilized, peaking in 2022. The United States and China were major contributors, with leading institutions such as Harvard University, University of California, and Fudan University.\"}]","Worldwide Research Trends on the Immunotherapy-Based Treatment of Ovarian Cancers: A Bibliometric and Visual Analysis | PDF",1790172299,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ef2b603155e22763e61280ef0e1db11.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f730ff119233f7045154951b3d7dc1b8.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc01a02ca048fe6abe7dc8697c86839d.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74f2daef3e551b67a78beb39f46a1526.webp",980,1268]